Log In / Sign Up

HB 5494

  • Rhode Island House Bill
  • 2021 Regular Session
  • Introduced in House Feb 11, 2021
  • House
  • Senate
  • Governor

AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- DRUG COST TRANSPARENCY (Provides drug cost transparency by requiring reports be submitted by drug manufacturers, pharmacy benefit managers and health benefit plan insurers to the director of the department of business regulation regarding drug prices and increases the prices.)

View Latest Bill Text
Sign In to Follow

Bill Subjects

Business & Professions Food And Drugs Health Care Plans/Services Prescription Drugs

Abstract

Bill Sponsors (8)

Mia Ackerman

  • Democratic
  • Representative
  • District 45
Primary

Joseph McNamara

  • Democratic
  • Representative
  • District 19
Primary

Edith Ajello

  • Democratic
  • Representative
  • District 1
Primary

Brandon Potter

  • Democratic
  • Representative
  • District 16
Primary

David Morales

  • Democratic
  • Representative
  • District 7
Primary

Blake A. Filippi

  • Republican
Primary

Brianna Henries

  • Democratic
  • Representative
  • District 64
Primary

Karen Alzate

  • Democratic
  • Representative
  • District 60
Primary

Votes

No votes to display

Actions

Mar 08, 2021

Rhode Island General Assembly

03/08/2021 Committee recommended measure be held for further study

Mar 05, 2021

Rhode Island General Assembly

03/05/2021 Scheduled for hearing and/or consideration (03/08/2021)

Feb 11, 2021

House

02/11/2021 Introduced, referred to House Health & Human Services

Bill Text

Bill Text Versions Format
5494 PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Rhode Island General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.